Shenzhen Glory Medical Co.,Ltd. (SHE:002551)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Jan 1, 2020	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
Production and Sales of Medical Products	1.75B	2.08B	1.73B	1.92B	2.04B
Production and Sales of Medical Products Growth	-15.63%	20.19%	-9.68%	-6.08%	9.29%
Medical Services Division	186.22M	410.82M	322.68M	266.55M	752.41M
Medical Services Division Growth	-54.67%	27.32%	21.06%	-64.57%	104.31%
Intersegment elimination	-943.29M	-1.12B	-935.99M	-971.42M	-1.06B
Health Industry Operations Division	79.64M	79.31M	75.87M	64.85M	56.44M
Health Industry Operations Division Growth	0.42%	4.53%	16.99%	14.90%	539.42%
Total	1.08B	1.45B	1.19B	1.28B	1.79B
Total Growth	-25.61%	21.40%	-6.49%	-28.74%	-20.20%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Jan 1, 2020	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
China	298.46M	516.51M	366.40M	477.70M	773.25M
China Growth	-42.21%	40.97%	-23.30%	-38.22%	1.17%
Foreign	778.84M	931.70M	826.48M	798.01M	1.02B
Foreign Growth	-16.41%	12.73%	3.57%	-21.54%	-32.33%
Total	1.08B	1.45B	1.19B	1.28B	1.79B
Total Growth	-25.61%	21.40%	-6.49%	-28.74%	-21.04%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error